Public procurement notice: Contract Notice
Published: 2020-02-25
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 11000000 GBP
Submission deadline: 2020-03-23
Award criteria: The most economic tender

Technical requirements: The framework is for the supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to health boards across NHS Scotland.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978 and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of rituximab 100 mg and 500 mg intravenous infusion vials to NHS Scotland.
The authority intends to award this lot as an unranked multi-supplier framework per line to and envisaged maximum of 6 framework participants.
This framework includes the option(s) to extend for up to a total period of 24 months upon giving not less than 3 months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978 and any integrated joint boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of trastuzumab 100 mg and 440 mg intravenous infusion vials to NHS Scotland.
The authority intends to award this lot as an unranked multi-supplier framework per line to and envisaged maximum of 6 framework participants.
This framework includes the option(s) to extend for up to a total period of 24 months upon giving not less than 3 months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods for the commencement of the framework agreement;
(b) potential framework participants and any subcontractor(s) must possess valid certification of BS EN ISO 9001 or equivalent;
(c) all tendered goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (‘NPSA’) Guidelines on Packaging and Labelling on pack design.
(a) confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods will be in place for the start date of the framework agreement should be included in the qualification envelope of the ITT under the technical and professional ability: quality control;
(b) confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the qualification envelope of the ITT under the quality assurance schemes;

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 11000000